Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Substituted Indole. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111072605B details a visible-light catalyzed method for fluoroalkyl-substituted benzofurans. Offers mild conditions and high yields for pharma intermediates.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Delivers high stereoselectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115215783B reveals high-yield copper catalysis for chiral oxindoles. Enables cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115215783B reveals novel copper-catalyzed synthesis for chiral oxindoles. Enables cost reduction in pharmaceutical intermediate manufacturing with high stereoselectivity.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Patent CN109879792B enables efficient Rh-catalyzed oxidative Heck reaction for isoindoles. Delivers high purity, reduced steps, and scalable supply chain solutions.
Patent CN102659494A discloses a novel organocatalytic route for 3,3-disubstituted-2-oxindoles, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN102659494B details a novel chiral organic catalytic method for high-purity 3,3-disubstituted-2-oxindoles, offering significant cost and supply chain advantages.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Patent CN109879792B details a Rh-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharma intermediates with improved atom economy.
Advanced copper-catalyzed oxidative cyclization for 2-aryl indoles. Reduces heavy metal usage and simplifies purification for pharmaceutical intermediates.
Patent CN109879792B details a Rh(III)-catalyzed oxidative Heck reaction for isoindoles. Offers efficient route for pharma intermediates with reduced steps.
Novel indole-based phosphine ligands enable efficient C-S bond formation with high yields, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN115215783A details a novel copper-catalyzed synthesis of chiral propargyl-substituted oxindoles, offering high stereoselectivity and cost reduction in API manufacturing.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Patent CN101492407B details a mild organocatalytic route for high-purity beta-indolaldehyde, offering significant cost and environmental benefits for pharma manufacturing.
Novel Cu(I)-catalyzed cyclization for 2,3-disubstituted indoles. High yield, mild conditions, cost-effective scale-up for pharmaceutical intermediates.
Novel Pd-catalyzed radical tandem cyclization for fluoroalkyl-substituted pyrrole[1,2-a]indoles. Green, efficient route reducing costs in API manufacturing.